With over 32 years of experience, Scott Selleck guides clients through luxury sales, downsizing, and multi-family ...
Alkermes (ALKS) shifts to fully integrated biopharma, leveraging Vibrance-2, Lybalvi growth, and Avadel buy to de-risk ...
Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, ...
Q1 2026 earnings call recap: 10.6% sales growth, membership gains, margin strength, and expansion plans for Chile.
Q2 2026 Earnings Call Transcript January 6, 2026 AAR Corp. beats earnings expectations. Reported EPS is $1.18, expectations ...
From entertainment-led flagships to hyper-localized experiences and old-school clienteling, industry insiders share how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback